(Q72306431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7778543%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7778543%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

language of work or name

English

0 references

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7778543%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7778543%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7778543%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7778543%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

1220-1223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7778543%20AND%20SRC:MED&resulttype=core&format=json

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

25 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Usefulness of bucindolol in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

The paradox of beta-adrenergic blockade for the management of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Unwanted effects of propranolol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Effects of bucindolol in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Sample size determination in clinical trials with time-dependent rates of losses and noncompliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

Sample Sizes Based on the Log-Rank Statistic in Complex Clinical Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980766-8

10.1016/S0002-9149(99)80766-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7778543%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference